International Law

FDA Comes to China II

By Stan

Yesterday, I posed the question whether the U.S. FDA had the resources to adequately conduct inspections over here in China. Here is one opinion, and it’s a negative one:

The FDA is overburdened and underfunded; it has trouble policing domestic pharmaceutical companies adequately. So how does the government and pharmaceutical companies think they can adequately monitor ingredients made in China?

Full post as published by China Hearsay on April 17, 2008 (boomark / email).